Amy Strelzer Manasevit Research Program

The Amy Strelzer Manasevit Research Program for the Study of Post-Transplant Complications (Amy Research Program) is one of the largest and most coveted grants in the field of transplantation and cellular therapy. The grant supports the research endeavors of basic scientists and clinicians early in their careers. Its goal is to launch these young investigators on a life-long journey to discover solutions to potentially life-threatening post-transplant or post-cellular therapy complications such as infection, relapse, or graft-versus-host disease.

The emphasis on early career support attracts new talent to the field and encourages the researchers to focus on these complications throughout their careers. Amy Scholars (2021) receive a maximum of $400,000 divided over five years from the Be The Match Foundation®. Grant terms (number of grants awarded, amount, length of grant, etc.) are evaluated and determined each year. This crucial funding enables the researchers to continue with their projects without having to stop and apply for further financial support.

Please note: the grant program is closed for 2021 applications. We anticipate the 2022 RFP will be released in September 2021.

Grant History

The program was established in 1997 to honor the memory of Amy Strelzer Manasevit. A vibrant young mother of two, Amy was diagnosed with multiple myeloma in 1993. After receiving a successful marrow transplant, she succumbed to pneumonia and passed away six weeks after returning home. Manasevit’s family and friends partnered with the NMDP/Be The Match to establish the research program in the hope they could prevent other families from losing their loved ones.

Contact us for more information about the Amy Strelzer Manasevit Research Program.